Therefore, our key solution to achieve a true AND gate tumor targeting, where T cells become completely activated only when both the CD3z and CD28 signals are induced upon recognition of two TAAs simultaneously, was the expression level and ratio of the two receptors mediating the activation or the co-stimulatory signal. The gene discussed is CD28; the disease is neoplasm.